A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
暂无分享,去创建一个
R. Scheyer | A. Bar-Or | D. Paty | M. Freedman | David K.B. Li | G. Rice | C. Confavreux | D. Li | P. O'Connor | J. Stewart | P. O'Connor
[1] David H. Miller,et al. A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.
[2] M. Filippi,et al. MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients , 2002, Neurology.
[3] H. Hartung,et al. Suppression of experimental autoimmune neuritis by leflunomide. , 2001, Brain : a journal of neurology.
[4] Massimo Filippi,et al. European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , 2001, Annals of neurology.
[5] D. Paty,et al. Magnetic resonance imaging results of the PRISMS trial: A randomized, double‐blind, placebo‐controlled study of interferon‐β1a in relapsing‐remitting multiple sclerosis , 1999 .
[6] R. Williamson,et al. Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. , 1998, The Biochemical journal.
[7] Jeanelle Sheeder,et al. Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis , 1998 .
[8] C. Granger,et al. Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis , 1996, Annals of neurology.
[9] J. Cooper,et al. Mitochondrial defect in Huntington's disease caudate nucleus , 1996, Annals of neurology.
[10] H. Cherwinski,et al. The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis. , 1995, The Journal of pharmacology and experimental therapeutics.
[11] A. A. Eisen,et al. MRI in the diagnosis of MS , 1988, Neurology.
[12] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[13] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.